All Pharma News
Otsuka buys Mindset for CAD 80M to strengthen pipeline in neurological disorders

Otsuka buys Mindset for CAD 80M to strengthen pipeline in neurological disorders
BIOSPECTRUM ASIA
04 Sep 2023
Share Share
Otsuka Pharmaceutical to Acquire Mindset Pharma

Otsuka Pharmaceutical to Acquire Mindset Pharma
BIOSPACE
01 Sep 2023
Share Share
UK trial to test psilocin-based drug for major depressive disorder

UK trial to test psilocin-based drug for major depressive disorder
Catherine Eckford EUROPEAN PHARMACEUTICAL REVIEW
28 Jun 2023
Share Share
Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic
GLOBENEWSWIRE
26 Apr 2023
Share Share
Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference

Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference
GLOBENEWSWIRE
03 Apr 2023
Share Share
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders
GLOBENEWSWIRE
28 Mar 2023
Share Share
Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences
GLOBENEWSWIRE
14 Mar 2023
Share Share
Mindset and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin

Mindset and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin
GLOBENEWSWIRE
06 Mar 2023
Share Share
Mindset Pharma Receives Allowance from USPTO for Patent Application

Mindset Pharma Receives Allowance from USPTO for Patent Application
GLOBENEWSWIRE
02 Feb 2023
Share Share
Mindset Receives Allowance for U.S. Patent Application for MSP-1014

Mindset Receives Allowance for U.S. Patent Application for MSP-1014
GLOBENEWSWIRE
20 Jan 2023
Share Share